Literature DB >> 23036739

Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.

Simona Osella-Abate, Mauro Novelli, Pietro Quaglino, Francesca Orso, Benedetta Ubezio, Carlo Tomasini, Ester Berardengo, Maria Grazia Bernengo, Daniela Taverna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23036739     DOI： 10.1016/j.jdermsci.2012.09.008

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  5 in total

1.  Tyrosine phosphorylation of the orphan receptor ESDN/DCBLD2 serves as a scaffold for the signaling adaptor CrkL.

Authors:  Tyler M Aten; Miranda M Redmond; Sheila O Weaver; Collin C Love; Ryan M Joy; Aliya S Lapp; Osvaldo D Rivera; Karen L Hinkle; Bryan A Ballif
Journal:  FEBS Lett       Date:  2013-06-13       Impact factor: 4.124

2.  ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3.

Authors:  Roberto Coppo; Francesca Orso; Federico Virga; Alberto Dalmasso; Desirée Baruffaldi; Lei Nie; Fabiana Clapero; Daniela Dettori; Lorena Quirico; Elena Grassi; Paola Defilippi; Paolo Provero; Donatella Valdembri; Guido Serini; Mehran M Sadeghi; Massimiliano Mazzone; Daniela Taverna
Journal:  Cancer Lett       Date:  2021-04-13       Impact factor: 9.756

3.  FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family.

Authors:  Anna M Schmoker; Jaye L Weinert; Jacob M Markwood; Kathryn S Albretsen; Michelle L Lunde; Marion E Weir; Alicia M Ebert; Karen L Hinkle; Bryan A Ballif
Journal:  Mol Cell Proteomics       Date:  2020-06-30       Impact factor: 5.911

Review 4.  Roles of activator protein-2 gamma in breast cancer: A narrative review (SANRA).

Authors:  Yifei Zhang; Asal Aa Mostafa; Natthida Sriboonvorakul; Jiamiao Hu
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

5.  Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2.

Authors:  Anna M Schmoker; Jaye L Weinert; Kyle J Kellett; Hannah E Johnson; Ryan M Joy; Marion E Weir; Alicia M Ebert; Bryan A Ballif
Journal:  Biochem J       Date:  2017-11-21       Impact factor: 3.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.